India, Feb. 1 -- image credit- freepik
The Union Budget for 2026-27 was presented by the Finance Minister Nirmala Sitharaman on 1st February 2026, right after which a surge of responses and views have been flowing in from the industry experts.
While some are praising the key announcements made for the biopharma, ayurveda and healthcare sectors in the Budget, others express further expectations.
"By placing biopharma among the seven strategic frontier sectors and launching Biopharma Shakti with an outlay of Rs10,000 crore over five years, the Union Budget makes a decisive investment in India's health and innovation future. As India's disease burden shifts toward cancer, diabetes and autoimmune disorders, biologics and biosimilars will b...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.